Renal Cell Carcinoma

Showing NaN - NaN of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,

Completed
  • Colorectal Cancer Metastatic
  • +6 more
  • EDP1503
  • Pembrolizumab
  • Rogers, Arkansas
  • +7 more
Nov 11, 2021

Disease Burden and Biology Using Tumor Cell Free DNA in

Recruiting
  • Renal Cell Carcinoma
  • Blood collection
  • Urine collection
  • Nashville, Tennessee
  • +2 more
Sep 1, 2021

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)

Completed
  • Renal Cell Carcinoma
  • Cabozantinib tablets
  • Everolimus (Afinitor) tablets
  • Birmingham, Alabama
  • +204 more
Apr 1, 2021

Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)

Terminated
  • Renal Cell Carcinoma
  • Birmingham, Alabama
  • +38 more
Oct 15, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)

Completed
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
  • +2 more
  • Scottsdale, Arizona
  • +44 more
Dec 19, 2019

Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

Terminated
  • Advanced Renal Cell Carcinoma
  • +2 more
  • Standard Treatment
  • AGS-003
  • Scottsdale, Arizona
  • +124 more
Jun 13, 2018

Renal Cell Carcinoma Trial in United States (Perifosine)

Completed
  • Renal Cell Carcinoma
  • Duarte, California
  • +3 more
Feb 27, 2018

Renal Cell Carcinoma, Kidney Cancer Trial in Boston, Nashville (bevacizumab, temsirolimus)

Completed
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Boston, Massachusetts
  • +2 more
Jan 1, 2018

Renal Cell Carcinoma Trial in Worldwide (Everolimus, GDC-0980)

Completed
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +21 more
Aug 8, 2016

Renal Cell Carcinoma Trial in Worldwide (Bevacizumab, Temsirolimus, Interferon-Alfa 9MU)

Completed
  • Renal Cell Carcinoma
  • Little Rock, Arkansas
  • +171 more
Mar 25, 2016

Renal Cell Carcinoma Trial in United States (ASONEP)

Terminated
  • Renal Cell Carcinoma
  • Duarte, California
  • +4 more
Jan 18, 2016

Renal Cell Carcinoma Trial in United States (Pazopanib)

Completed
  • Renal Cell Carcinoma
  • San Francisco, California
  • +16 more
May 18, 2015

Renal Cell Carcinoma Trial in United States (SGN-75, everolimus)

Terminated
  • Renal Cell Carcinoma
  • Stanford, California
  • +7 more
Jan 24, 2014

Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
    • Jonesboro, Arkansas
    • +7 more
    Nov 12, 2013

    Renal Cell Carcinoma Trial in Worldwide (autologous human tumor-derived HSPPC-96)

    Completed
    • Renal Cell Carcinoma
    • autologous human tumor-derived HSPPC-96
    • Anchorage, Alaska
    • +75 more
    Sep 6, 2012